Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-09-002634
Filing Date
2009-01-20
Accepted
2009-01-20 16:18:05
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v137464_10ka.htm 10-K/A 63678
2 v137464_ex31-1.htm EX-31.1 12766
3 v137464_ex31-2.htm EX-31.2 11334
4 v137464_ex32-1.htm EX-32.1 4074
5 v137464_ex32-2.htm EX-32.2 4143
  Complete submission text file 0001144204-09-002634.txt   97634
Mailing Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010
Business Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010 805-484-7687
Huifeng Bio-Pharmaceutical Technology, Inc. (Filer) CIK: 0001119951 (see all company filings)

EIN.: 870650264 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-32253 | Film No.: 09534420
SIC: 2833 Medicinal Chemicals & Botanical Products